Skip to main content
Log in

Diabetes technology and cybersecurity—a growing cause for concern

  • Letter to the Editor
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data availability

All relevant data are within the paper.

References

  1. Sun H., Saeedi P., Karuranga S., et al. IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Res. Clin. Pract. 183, (2022). https://doi.org/10.1016/j.diabres.2021.109119.

  2. Health C for D and R. Cybersecurity. FDA; 2022. https://www.fda.gov/medical-devices/digital-health-center-excellence/cybersecurity [Last accessed: 7/20/2022].

  3. D.C. Klonoff, Cybersecurity for Connected Diabetes Devices. J. Diabetes Sci. Technol. 9(5), 1143–1147 (2015). https://doi.org/10.1177/1932296815583334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. EUROSCIENTIST. Cybersecurity: An EU Health Challenge in the Post-Covid Era. 2022. https://www.euroscientist.com/cybersecurity-an-eu-health-challenge-in-the-post-covid-era/ [Last accessed: 7/20/2022].

  5. HealthITSecurity. FDA Recalls Medtronic Insulin Pump Controller, Cites Cybersecurity Risks. 2021. https://healthitsecurity.com/news/fda-recalls-medtronic-insulin-pump-controller-cites-cybersecurity-risks [Last accessed: 7/20/2022].

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors have made substantial contributions to (1) the conception and design of the study, or the acquisition of data or analysis and interpretation of data, (2) drafting the article and revising it critically, (3) final approval of the version to be published, and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors had full access to the data in the study and have approved the final version of the paper, including the authorship list. The paper included related data and tables has not been previously published and the paper is not under consideration elsewhere.

Corresponding author

Correspondence to Henrique Carmona Alexandrino.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carmona Alexandrino, H., Almeida Ferreira, M. & Oliveira, M.J. Diabetes technology and cybersecurity—a growing cause for concern. Endocrine 78, 392–393 (2022). https://doi.org/10.1007/s12020-022-03189-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-022-03189-3

Navigation